Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unfolding the action of progesterone receptors.

Literature DB >> 12893816

Unfolding the action of progesterone receptors.

Xiaotao Li¹, Bert W O'Malley.

Abstract

Mesh：

Substances：

Year: 2003 PMID： 12893816 DOI： 10.1074/jbc.R300024200

Source DB: PubMed Journal: J Biol Chem ISSN： 0021-9258 Impact factor: 5.157

Keyword Cloud
Cited

× No keyword cloud information.

68 in total

1. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

Authors: Victoria Wargon; Marina Riggio; Sebastián Giulianelli; Gonzalo R Sequeira; Paola Rojas; María May; María L Polo; María A Gorostiaga; Britta Jacobsen; Alfredo Molinolo; Virginia Novaro; Claudia Lanari
Journal: Int J Cancer Date: 2014-11-12 Impact factor: 7.396

2. Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors: Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal: Mol Endocrinol Date: 2011-01-27

3. Effects of progesterone on the growth regulation in classical progesterone receptor-negative malignant melanoma cells.

Authors: Xianfeng Fang; Xuxin Zhang; Meng Zhou; Jiawen Li
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2010-04-21

Review 4. Role of nuclear receptors in blastocyst implantation.

Authors: Y M Vasquez; F J DeMayo
Journal: Semin Cell Dev Biol Date: 2013-08-28 Impact factor: 7.727

5. Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors: Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal: Proc Natl Acad Sci U S A Date: 2020-12-01 Impact factor: 11.205

10. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors: Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal: Mol Endocrinol Date: 2009-12-11

Unfolding the action of progesterone receptors.

1. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

2. Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

3. Effects of progesterone on the growth regulation in classical progesterone receptor-negative malignant melanoma cells.

Review 4. Role of nuclear receptors in blastocyst implantation.

5. Targeting progesterone signaling prevents metastatic ovarian cancer.

6. Hypothetical protein At2g24940.1 from Arabidopsis thaliana has a cytochrome b5 like fold.

7. The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.

8. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.

9. Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.

10. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.